Global Health Community (GHC)

Time

Location

Poster / Presentation

Speaker

Title

9:00

155F

Presentation

Alex Langford, Pfizer

Accelerating Development of Vaccines for Low- and Middle-Income Countries

9:30

04-22

Poster

A Catalytic Aldicarb Bioscavenger as a Treatment for Aldicarb Poisoning

9:30

04-20

Poster

An Innovative Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid toward Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity Against MRSA

9:30

09-52

Poster

Development and Characterization of pH-Sensitive, Ionizable Hybrid Nanocarriers for Enhanced Drug Delivery to Bacterial Biofilms

9:30

05-27

Poster

Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones

9:30

03-16

Poster

Optimizing Storage Conditions to Maintain Chemical Stability and Aerodynamic Performance of Tigecycline Inhalation Powder

10:30

02-12

Poster

Investigating Differences in the Pharmacokinetics of Monoclonal Antibodies in Japanese and Non-Japanese Subjects

10:30

03-17

Poster

Bioresponsive Hydrogel Compositions Designed to Fortify Natural Contraceptive Barrier Properties of the Cervicovaginal Environment in Humans

11:30

07-40

Poster

Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection

11:30

03-17

Poster

Enhancing Gonorrhea Vaccine Efficacy: Dosage Response Analysis of a Novel Microparticulate Formulation

12:30

09-52

Poster

An Exploratory Study of DHA-Incorporated Nanoformulations for Delivery of Antiretrovirals to Lymphatic HIV-Reservoirs

13:30

251 DE

Presentation

Brian Corrigan, Pfizer

Keynote: From Theory to Therapy: Charting the Course from the Lab to Global Health Outcomes in Translational Science

13:30

Careers 360

Presentation

Allison Radwick

Innovating Together: How Diversity Drives Team Science Success, Allison Radwick

13:30

05-27

Poster

Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery

13:30

01-06

Poster

Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections

13:30

01-05

Poster

Is a Minimally Invasive Amphotericin B Treatment Feasible? Nanocrystals-Loaded Microneedles for Cutaneous Leishmaniasis

13:30

05-29

Poster

Self-Nanoemulsifying Systems Containing Ionic Liquids of Rilpivirine for Improved Oral Bioavailability and Penetration in the HIV Sanctuary Sites

14:30

05-29

Poster

Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness

14:30

09-51

Poster

Aerosolizable Drug Loaded Superparamagnetic Iron Oxide Nanoparticle Theranostic for Pulmonary Tuberculosis

14:30

01-03

Poster

Development of a Coextrusion Process to Prepare Etonogestrel Long-Acting Implant

14:30

09-52

Poster

Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery

14:30

04-22

Poster

Discovery and Development of a New Therapeutic Product for the Treatment Long Covid

14:30

03-17

Poster

Targeted Antiretroviral Therapy Using Controlled Release Polymeric Nanoparticles for Brain Viral Load Reduction and Management of HIV Associated Neurocognitive Disorder (HAND)

15:30

10-59

Poster

Antimicrobial Polymer-siRNA Polyplexes as a Dual-Mode Platform for the Treatment of Wound Biofilm Infection and Inflammation Control

15:30

04-22

Poster

Anti-Viral and Anti-Inflammatory Effects of Novel PPARγ Agonist, INT131, in an EcoHIV Mouse Model: Relevance to the Treatment of HIV-Associated Neurocognitive Disorders

15:30

01-54

Poster

Development of an Aerosolizable Dry Powder of Mycobacteriophage D29 Using Thin-Film Freeze-Drying

15:30

06-35

Poster

Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations

16:00

Spotlight Stage C

Meeting

Global Health Community Meeting

Time

Location

Poster / Presentation

Speaker

Title

7:00

Salt Lak AB

Event

Mentor Breakfast

9:30

05-26

Poster

On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation

10:30

05-26

Poster

3D-Printed Short Nanofibers/Hydrogel-Based Vaginal Films as a Novel System for the Delivery of Anti-HIV Microbicide Drugs

10:30

3-16

Poster

Baru Nuts and Chia Seeds Extracts as Stabilizer in Nanostructured Formulation for Optimized Antifungal Drug Delivery of Fluconazole

10:30

251 F

Presentation

Reina Bendayan, University of Toronto

Novel Molecular Targets for the Treatment of HIV-Associated Neurocognitive Disorders

11:30

01-06

Poster

Nystatin-Loaded Microneedles via MeltPreP Vacuum Compression Molding for Prolonged Defense Against Candida albicans

12:30

05-30

Poster

ontrolled Release Mannose and RVG-9R Functionalized PLGA Nanoparticles for Targeting the Brain Viral Reservoir for the Management of HIV Associated Neurocognitive Disorder

12:30

03-17

Poster

Development of Long-Acting Decoquinate Nanocrystal-Based Formulations as a Chemical Vaccine for Malaria

12:30

05*25

Poster

How are Medicines Administered to Pre-school Children? Current Status of a Global Survey on the Use of Dosing Vehicles

14:30

01-02

Poster

Development of an Extended Action Fostemsavir (FTR) Lipid Nanoparticle (LNP) Antiretroviral Therapy

14:30

03-16

Poster

Development of Microemulsion Formulations with D-Limonene and Terbinafine Hydrochloride for Treatment of Cutaneous Fungal Infections

15:30

05-25

Poster

Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria

Time

Location

Poster / Presentation

Speaker

Title

1:30

155C

Presentation

Beate Bittner, Roche

Keynote: Customer-Centric Product Presentations for Monoclonal Antibodies - Innovative Approaches to Improve Access to Healthcare

9:00

251ABC

Presentation

Rohit Rao, Pfizer

Model-Informed Vaccine Development Opportunities

9:00

251DE

Presentation

Wendy Picking, University of Missouri-Columbia

A Dual Prophylactic/therapeutic Vaccine Against Pseudomonas Aeruginosa, Wendy Picking

9:30

251ABC

Presentation

Jeffrey Sachs, Merck

Pharmacometrics Symbiotically Infects Vaccinology: MIDD for Increasing PoS and Reducing Resource Use

9:30

251DE

Presentation

Li Li, Pfizer

Patient Focused Vaccine Drug Product Development: Formulation, Process and Manufacturing Approaches

9:30

155B

Presentation

Pavan Muttil, University of New Mexico

Inhaled Vaccines: Advancing Respiratory Infection Prevention and Overcoming Current Limitation

10:00

251ABC

Presentation

Will Lykins, AAHI

Case Studies of Rational Design and Translation for Next-Generation Vaccine Adjuvants

10:00

155F

Presentation

Ahmed Zidan, US FDA

Distributed Manufacturing: Personalization of 3DPrinted Intravaginal-Rings by Droplet Deposition Modeling

10:00

150DEFG

Presentation

Chaitanya Koduri, US Pharmacopeia

Collaborative Training Initiatives for Strengthening Regulatory and Laboratory Systems

10:30

04-22

Poster

Antimicrobial Effects of S-nitrosothiols on Mycobacterium abscessus Biofilms

10:30

11-60

Poster

Canada and the World: A Comparative Global Regulatory and Quality Variability Study of Melatonin Health Products

10:30

09-48

Poster

Comparison of Plant and Animal Sources of Squalene as Adjuvants for Use in Vaccine Applications